Melis M - Search Results

1

Nephrotoxicity in mice after repeated imaging using 111In-labeled peptides.

Melis M, Vegt E, Konijnenberg MW, de Visser M, Bijster M, Vermeij M, Krenning EP, Boerman OC, de Jong M. Melis M, et al. J Nucl Med. 2010 Jun;51(6):973-7. doi: 10.2967/jnumed.109.074310. Epub 2010 May 19. J Nucl Med. 2010. PMID: 20484435 Free article.

2

Localisation and mechanism of renal retention of radiolabelled somatostatin analogues.

Melis M, Krenning EP, Bernard BF, Barone R, Visser TJ, de Jong M. Melis M, et al. Eur J Nucl Med Mol Imaging. 2005 Oct;32(10):1136-43. doi: 10.1007/s00259-005-1793-0. Epub 2005 May 24. Eur J Nucl Med Mol Imaging. 2005. PMID: 15912401

3

Megalin is essential for renal proximal tubule reabsorption of (111)In-DTPA-octreotide.

de Jong M, Barone R, Krenning E, Bernard B, Melis M, Visser T, Gekle M, Willnow TE, Walrand S, Jamar F, Pauwels S. de Jong M, et al. Among authors: melis m. J Nucl Med. 2005 Oct;46(10):1696-700. J Nucl Med. 2005. PMID: 16204720 Free article.

4

Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts.

de Visser M, van Weerden WM, de Ridder CM, Reneman S, Melis M, Krenning EP, de Jong M. de Visser M, et al. Among authors: melis m. J Nucl Med. 2007 Jan;48(1):88-93. J Nucl Med. 2007. PMID: 17204703 Free article.

5

Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: species and gender differences.

Melis M, Krenning EP, Bernard BF, de Visser M, Rolleman E, de Jong M. Melis M, et al. Nucl Med Biol. 2007 Aug;34(6):633-41. doi: 10.1016/j.nucmedbio.2007.05.002. Nucl Med Biol. 2007. PMID: 17707803

6

Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours.

Melis M, Bijster M, de Visser M, Konijnenberg MW, de Swart J, Rolleman EJ, Boerman OC, Krenning EP, de Jong M. Melis M, et al. Eur J Nucl Med Mol Imaging. 2009 Dec;36(12):1968-76. doi: 10.1007/s00259-009-1196-8. Eur J Nucl Med Mol Imaging. 2009. PMID: 19585115 Free PMC article.

7

Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues.

Rolleman EJ, Melis M, Valkema R, Boerman OC, Krenning EP, de Jong M. Rolleman EJ, et al. Among authors: melis m. Eur J Nucl Med Mol Imaging. 2010 May;37(5):1018-31. doi: 10.1007/s00259-009-1282-y. Epub 2009 Nov 14. Eur J Nucl Med Mol Imaging. 2010. PMID: 19915842 Review.

8

Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention.

Vegt E, de Jong M, Wetzels JF, Masereeuw R, Melis M, Oyen WJ, Gotthardt M, Boerman OC. Vegt E, et al. Among authors: melis m. J Nucl Med. 2010 Jul;51(7):1049-58. doi: 10.2967/jnumed.110.075101. Epub 2010 Jun 16. J Nucl Med. 2010. PMID: 20554737 Free article. Review.

9

Dynamic and static small-animal SPECT in rats for monitoring renal function after 177Lu-labeled Tyr3-octreotate radionuclide therapy.

Melis M, de Swart J, de Visser M, Berndsen SC, Koelewijn S, Valkema R, Boerman OC, Krenning EP, de Jong M. Melis M, et al. J Nucl Med. 2010 Dec;51(12):1962-8. doi: 10.2967/jnumed.110.080143. Epub 2010 Nov 15. J Nucl Med. 2010. PMID: 21078795 Free article.

10

Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice.

Vegt E, Melis M, Eek A, de Visser M, Brom M, Oyen WJ, Gotthardt M, de Jong M, Boerman OC. Vegt E, et al. Among authors: melis m. Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):623-32. doi: 10.1007/s00259-010-1685-9. Epub 2010 Dec 18. Eur J Nucl Med Mol Imaging. 2011. PMID: 21170526 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,106 results

Search Page

Filters